Stereotaxis Inc
stereotaxis.comWhat Do They Do?
Designs and sells robotic navigation systems, interventional devices and information systems for hospitals and physicians performing cardiac and other endovascular procedures.
10-K for FY2025, filed Mar 12, 2026Stereotaxis designs, manufactures and markets robotic systems, instruments and information systems for the interventional laboratory. Our…View ↗
Our primary clinical focus has been electrophysiology, specifically cardiac ablation procedures for the treatment of arrhythmias. Cardiac…View ↗
Our primary products include the Genesis RMN and the GenesisX RMN Systems, the Odyssey and Synchrony & SynX Solutions, various…View ↗
How Do They Make Money?
Most revenue comes from disposables, service and accessories: disposable products are counted when shipped or delivered, while service and software updates bring in payments over time. Hospitals also buy systems and installation, counted when delivery or installation is accepted.
10-K for FY2025, filed Mar 12, 2026We promote our full suite of products necessary for a typical hospital implementation, subject to regulatory approvals or clearances. This…View ↗
Contracts related to the sale of systems typically contain separate obligations for the delivery of system(s), installation, and…View ↗
Revenue from sales of disposable products is recognized when control is transferred to the customers, which generally occurs at the time of…View ↗
-
10-K for FY2025, filed Mar 12, 2026
FY2025 revenue by product or service ↗
$32.4M
-
10-K for FY2025, filed Mar 12, 2026
$32.4M ↗
| Segment | Share | Revenue | How money arrives |
|---|---|---|---|
|
Systems
Mix
10-K for FY2025, filed Mar 12, 2026 |
32%
FY2022: 24%
|
Systems, FY2025
$10.2M Sources
|
Mix |
|
Disposables Service and Accessories
|
68%
FY2022: 76%
|
Disposables Service and Accessories, FY2025
$22.2M Sources
|
Who Are Their Customers?
Hospitals buy systems directly or through distributors; physicians use the devices, and Stereotaxis markets products through direct sales staff, distributors and sales agents.
10-K for FY2025, filed Mar 12, 2026We pursue arrangements with fluoroscopy system manufacturers to provide RMN Systems in a bundled purchase offer for hospitals establishing…View ↗
We market our products in the U.S and internationally through a direct sales force of senior sales specialists, distributors and sales…View ↗
Our sales and marketing efforts include two important elements: (1) selling robotic magnetic systems, the Odyssey and Synchrony & SynX…View ↗
Do Revenues Turn Into Profits?
No. It lost $21.6M in FY2025.
10-K for FY2025, filed Mar 12, 2026
−$22.1MView ↗
10-K for FY2025, filed Mar 12, 2026
−$21.6MView ↗
10-K for FY2025, filed Mar 12, 2026
−$13.8MView ↗
How Are They Changing?
- Net income
-
Sources
10-Q for Q2 FY2026, filed Aug 12, 2026
−$4.5MView ↗
- ▲ +17% (Loss)
- vs −$3.8M in Q2 FY2025
10-Q for Q2 FY2026, filed Aug 12, 2026
Open tableView ↗
Flat. Revenue was $32.4M in FY2025, about the same as the $35M of FY2021.
Digital lab solutions
The earlier report centers its digital offering on Odyssey and Odyssey Cinema; the latest says they are being replaced by Synchrony and SynX, which add consolidated displays and remote connectivity.
10-K for FY2022, filed Mar 9, 2023 10-K for FY2025, filed Mar 12, 2026The Odyssey Solution consolidates lab information onto one large integrated display, enabling physicians to view and control all the key…View ↗
The Odyssey Solution consolidates lab information onto one large integrated display, enabling physicians to view and control all the key…View ↗
More interventional devices
The earlier report named Genesis RMN and Odyssey as primary products; the latest includes Map-iT, MAGiC and EMAGIN interventional devices, including Map-iT catheters from APT.
10-K for FY2022, filed Mar 9, 2023 10-K for FY2025, filed Mar 12, 2026Our primary products include the Genesis RMN System, the Odyssey Solution, and other related devices. We also offer to our customers the…View ↗
Loading...
